Skip to main content

The need for an integrated approach for chronic disease research and care in Africa

  • A. L. Barr (a1) (a2), E. H. Young (a1) (a2), L. Smeeth (a3), R. Newton (a4), J. Seeley (a4) (a5), K. Ripullone (a1) (a2), T. R. Hird (a1) (a2), J. R. M. Thornton (a1) (a2), M. J. Nyirenda (a3) (a6), S. Kapiga (a3) (a7), C. A. Adebamowo (a8) (a9), A. G. Amoah (a10), N. Wareham (a11), C. N. Rotimi (a12), N. S. Levitt (a13), K. Ramaiya (a14), B. J. Hennig (a15) (a16), J. C. Mbanya (a17), S. Tollman (a18) (a19), A. A. Motala (a20), P. Kaleebu (a4) and M. S. Sandhu (a1) (a2)...

With the changing distribution of infectious diseases, and an increase in the burden of non-communicable diseases, low- and middle-income countries, including those in Africa, will need to expand their health care capacities to effectively respond to these epidemiological transitions. The interrelated risk factors for chronic infectious and non-communicable diseases and the need for long-term disease management, argue for combined strategies to understand their underlying causes and to design strategies for effective prevention and long-term care. Through multidisciplinary research and implementation partnerships, we advocate an integrated approach for research and healthcare for chronic diseases in Africa.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The need for an integrated approach for chronic disease research and care in Africa
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      The need for an integrated approach for chronic disease research and care in Africa
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      The need for an integrated approach for chronic disease research and care in Africa
      Available formats
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (, which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited
Corresponding author
*Address for correspondence: M. S Sandhu, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, CB10 1SA, UK. (Email:
Hide All
1. United Nations. Population and Vitals Statistics Report. 2015.
2. IDF. IDF Diabetes Atlas, 7th edn. Brussels: International Diabetes Federation, 2015.
3. WHO. Global health estimates summary tables: projection of deaths by cause, age and sex, by World Bank income groups: World Health Organization; 2013 [8th of June 2015]. (
4. WHO. Global Status Report on Non-communicable Diseases 2010. Geneva: World Health Organization, 2011.
5. WHO. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
6. Gurdasani D, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature 2014; 517: 327332.
7. Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010; 127: 28932917.
8. Yusuf S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937952.
9. Murphy GA, et al. Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. International Journal of Epidemiology 2013; 42: 17401753.
10. BeLue R, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and Health 2009; 5: 10.
11. Riha J, et al. Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study. PLoS Medicine 2014; 11: e1001683.
12. Assah FK, et al. Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care 2011; 34: 491496.
13. Sobngwi E, et al. Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. International Journal of Epidemiology 2004; 33: 769776.
14. Hawkes C. Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases. Globalization and Health 2006; 2: 4.
15. Kavishe B, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Medicine 2015; 13: 126.
16. Ng M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766781.
17. Torloni MR, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews 2009; 10: 194203.
18. Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. British Journal of Obstetrics and Gynaecology 2006; 113: 11171125.
19. Yogev Y, Visser GHA. Obesity, gestational diabetes and pregnancy outcome. Seminars in Fetal and Neonatal Medicine 2009; 14: 7784.
20. Wendland EM, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth 2012; 12: 23.
21. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine 2004; 21: 103113.
22. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 18621868.
23. Kaul P, et al. Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis. Diabetic Medicine 2014; 32: 164173.
24. Boney CM, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290e296.
25. Uauy R, Kain J, Corvalan C. How can the Developmental Origins of Health and Disease (DOHaD) hypothesis contribute to improving health in developing countries? American Journal of Clinical Nutrition 2011; 94(6 Suppl.): 1759s1764s.
26. Barker DJ. Fetal origins of coronary heart disease. BMJ (Clinical research ed) 1995; 311: 171174.
27. Barker DJ, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938941.
28. Gluckman PD, Hanson MA, Beedle AS. Non-genomic transgenerational inheritance of disease risk. BioEssays 2007; 29: 145154.
29. Barker DJ. The origins of the developmental origins theory. Journal of Internal Medicine 2007; 261: 412417.
30. Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nature Clinical Practice Nephrology 2006; 2: 700707.
31. UNAIDS. How AIDS Changed Everything Report – 2015. Geneva: UNAIDS, 2015.
32. Pawlowski A, et al. Tuberculosis and HIV Co-Infection. Plos Pathogens 2012; 8: e1002464.
33. WHO. Tuberculosis; fact sheet No. 104 2015. (
34. UNAIDS. Access to Antiretroviral Therapy in Africa; Status Report on Progress Towards the 2015 Targets. Geneva: UNAIDS, 2013.
35. WHO. Antimicrobial Resistance; Global Report on Surveillance. Geneva: World Health Organisation, 2014.
36. Okeke IN, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Diseases 2005; 5: 481493.
37. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860867.
38. Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nature Reviews Clinical Oncology 2015; 12: 584596.
39. Young F, et al. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health 2009; 5: 9.
40. Dillon DG, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. International Journal of Epidemiology 2013; 42: 17541771.
41. Brown TT, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine 2005; 165: 11791184.
42. De Wit S, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31: 12241229.
43. Triant VA, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism 2007; 92: 25062512.
44. Shintani Y, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840848.
45. Marzouk D, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007; 56: 11051110.
46. Wang CS, et al. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. American Journal of Epidemiology 2007; 166: 196203.
47. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 2006; 3: 4752.
48. Wang C, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. International Journal of Cancer Journal international du cancer 2012; 130: 16391648.
49. Genovese G, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841845.
50. Gaziano TA, et al. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Medicine 2013; 11: 170.
51. Motala AA, et al. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care 2011; 34: 10321037.
52. Crowther NJ, Norris SA. The current waist circumference cut point used for the diagnosis of metabolic syndrome in Sub-Saharan African women is not appropriate. PLoS ONE 2012; 7: e48883.
53. Mensah GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Progress in Cardiovascular Diseases 2013; 56: 240250.
54. Bonita R. Guest editorial: strengthening NCD prevention through risk factor surveillance. Global Health Action 2009; 2: 46.
55. Murphy GA, et al. Cardiometabolic risk in a rural Ugandan population. Diabetes Care 2013; 36: e143.
56. Kahn K, et al. Validation and application of verbal autopsies in a rural area of South Africa. Tropical Medicine & International Health: TM & IH 2000; 5: 824831.
57. INDEPTH Network. 2015. (
58. Asiki G, et al. The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. International Journal of Epidemiology 2013; 42: 129141.
59. Ng N, et al. Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scandinavian Journal of Public Health 2006; 34: 199208.
60. WHO. WHO STEPS Instrument (Core and Expanded): The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance (STEPS). Geneva: World Health Organization, 2016.
61. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet 2006; 368: 16891695.
62. Maseko FC, Chirwa ML, Muula AS. Health systems challenges in cervical cancer prevention program in Malawi. Global Health Action 2015; 8: 26282.
63. Janssens B, et al. Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bulletin of the World Health Organization 2007; 85: 880885.
64. Atun R, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet 2013; 381: 690697.
65. van Olmen J, et al. Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. Journal of Tropical Medicine 2012; 2012: 349312.
66. WHO. Package of Essenrtial Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: World Health Organization, 2010.
67. Beaglehole R, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet 2008; 372: 940949.
68. Maher D, et al. Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical Medicine & International Health: TM & IH 2010; 15: 176181.
69. Mahomed OH, Asmall S. Development and implementation of an integrated chronic disease model in South Africa: lessons in the management of change through improving the quality of clinical practice. International Journal of Integrated Care 2015; 15: e038.
70. de-Graft Aikins A, Boynton P, Atanga LL. Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon. Globalization and Health 2010; 6: 6.
71. Aminkeng F, et al. Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent. Pharmacogenomics Journal 2014; 14: 160170.
72. Ramos E, et al. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics Journal 2014; 14: 217222.
73. Drain PK, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infectious Diseases 2014; 14: 239249.
74. Pai NP, et al. Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection: findings from a systematic review (1996–2014). Point of Care 2015; 14: 8187.
75. Horton R. Offline: chronic diseases – the social justice issue of our time. Lancet 2016: 386: 2378.
76. Collins R. What makes UK Biobank special? Lancet 2012: 379: 11731174.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Global Health, Epidemiology and Genomics
  • ISSN: -
  • EISSN: 2054-4200
  • URL: /core/journals/global-health-epidemiology-and-genomics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 84
Total number of PDF views: 205 *
Loading metrics...

Abstract views

Total abstract views: 545 *
Loading metrics...

* Views captured on Cambridge Core between 29th November 2016 - 17th November 2017. This data will be updated every 24 hours.